American Heart Journal
Volume 148, Issue 5 , Pages 739-742 , November 2004

Evidence-based decision limits for cardiac troponin: Low-level elevation and prognosis

  • David A. Morrow, MD, MPH

      Affiliations

    • TIMI Study Group and Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Mass, USA
    • Corresponding Author InformationReprint requests: David A. Morrow, MD, MPH, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

  • Image Result

    Evolution of diagnostic criteria for MI, using cardiac troponin. See text for details. Current recommendations are for a single decision limit at the 99th percentile or, if there is not acceptable ana

    Evolution of diagnostic criteria for MI, using cardiac troponin. See text for details. Current recommendations are for a single decision limit at the 99th percentile or, if there is not acceptable analytic precision at this concentration, at the level of the 10% CV. MMD, Minor myocardial damage.

  • Image Result
    Example of a troponin assay with a CV of 10% at 0.1 ng/mL. Analytic performance of each troponin assay is characterized by repeated measurements on the same sample. CV is a measure of the precision of

    Example of a troponin assay with a CV of 10% at 0.1 ng/mL. Analytic performance of each troponin assay is characterized by repeated measurements on the same sample. CV is a measure of the precision of the assay at a given concentration. If the CV were 20% instead of 10% at this concentration, 67% of values from the same sample would fall within the range of 0.08 to 0.12 ng/mL and 95% within the range of 0.06 to 0.14 ng/mL.

PII: S0002-8703(04)00289-3

doi: 10.1016/j.ahj.2004.05.024

American Heart Journal
Volume 148, Issue 5 , Pages 739-742 , November 2004